Word

Status

Dead

Status Code

606

Status Date

Tuesday, July 5, 2011

Serial Number

77307521

Mark Type

2000

Filing Date

Thursday, October 18, 2007

Published for Opposition

Tuesday, March 11, 2008

Abandoned Date

Tuesday, July 5, 2011

Trademark Owner History

MAP Pharmaceuticals, Inc. - Owner At Publication

Classifications

5 Pharmaceutical products for use in the treatment of cardiovascular diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; drug delivery devices, namely, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the treatment of cardiovascular diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; drug delivery devices, namely, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the delivery of cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations

42 Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations, smoking cessation preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices, both with and without pre-filled drug cartridges, for delivery of medication via the pulmonary route; medical and scientific research, namely, conducting clinical trials

Color is not claimed as a feature of the mark.
The mark consists of a circular design with two intersecting curved lines.

Trademark Events

Jul 5, 2011

Abandonment Notice Mailed - No Use Statement Filed

Jul 5, 2011

Abandonment - No Use Statement Filed

Sep 4, 2010

Notice Of Approval Of Extension Request Mailed

Sep 3, 2010

Extension 5 Granted

Sep 1, 2010

Extension 5 Filed

Sep 1, 2010

Teas Extension Received

Apr 27, 2010

Notice Of Approval Of Extension Request Mailed

Apr 26, 2010

Extension 4 Granted

Apr 23, 2010

Extension 4 Filed

Apr 23, 2010

Teas Extension Received

Nov 9, 2009

Extension 3 Granted

Nov 6, 2009

Extension 3 Filed

Nov 6, 2009

Teas Extension Received

May 20, 2009

Extension 2 Granted

May 19, 2009

Extension 2 Filed

May 19, 2009

Teas Extension Received

Nov 18, 2008

Divisional Processing Complete

Nov 13, 2008

Divisional Request Received

Nov 18, 2008

Extension 1 Granted

Nov 13, 2008

Extension 1 Filed

Nov 17, 2008

Paper Received

Nov 17, 2008

Case Assigned To Intent To Use Paralegal

Nov 13, 2008

Teas Extension Received

Jun 3, 2008

Noa Mailed - Sou Required From Applicant

Mar 11, 2008

Published For Opposition

Feb 20, 2008

Notice Of Publication

Feb 1, 2008

Law Office Publication Review Completed

Jan 31, 2008

Examiner's Amendment Mailed

Jan 30, 2008

Approved For Pub - Principal Register

Jan 30, 2008

Examiner's Amendment Entered

Jan 30, 2008

Examiners Amendment -Written

Jan 29, 2008

Assigned To Examiner

Dec 26, 2007

Teas/Email Correspondence Entered

Dec 26, 2007

Correspondence Received In Law Office

Dec 26, 2007

Assigned To Lie

Nov 15, 2007

Teas Voluntary Amendment Received

Oct 24, 2007

Notice Of Design Search Code Mailed

Oct 23, 2007

New Application Entered In Tram